The scientific focus adapted
to express the optimum potential
of your molecule

Marketing:
Unparalleled vision in metabolic disorders and risk assessment expertise for post-marketing studies and drug repositioning.

HeartArteryMacrophageLiverMusclePancreasAdipose Tissue

Preclinical development:
In-house predictive models and tracer technologies enable the generation of Proof of Concept efficacy data for your drugs.

Discovery:
Screening and lead validation utilize a dedicated research platform which combine with our focused scientific vision.

Home > News > Physiogenex to present at the Keystone Conference on Drivers of Type 2 Diabetes in Seoul, Korea – October 7-12th, 2018

News detail

Return to all news & events

10/07/2018 Physiogenex to present at the Keystone Conference on Drivers of Type 2 Diabetes in Seoul, Korea – October 7-12th, 2018

Physiogenex will be presenting a hyperinsulinemic euglycemic clamp study differentiating insulin analogues in STZ-rats, a model of experimental diabetes.
The study will be presented by Dr. François Briand, Director of Research and Business Development, during the poster session 1, on Monday October the 8th, poster #1012.

If you wish to make an appointment during the meeting with Dr. François Briand to discuss about your drug development project, please contact us.